Company news

Eton Pharmaceuticals, Inc. news in 2025

Eton Pharmaceuticals, Inc.'s news releases, calls and decks from 2025, newest first.

View company

Eton Pharmaceuticals to Present at Piper Sandler 37th Annual Healthcare Conference on December 4th

November 23, 2025

Eton Pharmaceuticals to Participate at 16th Annual Craig-Hallum Alpha Select Conference on November 18th

November 11, 2025

Eton Pharmaceuticals Reports Third Quarter 2025 Financial Results

November 5, 2025

Eton Pharmaceuticals to Report Third Quarter 2025 Financial Results on Thursday, November 6, 2025

October 22, 2025

Eton Pharmaceuticals to Participate at 2025 Wells Fargo Healthcare Conference

August 19, 2025

Eton Pharmaceuticals Reports Second Quarter 2025 Financial Results

August 6, 2025

Eton Pharmaceuticals to Report Second Quarter 2025 Financial Results on Thursday, August 7, 2025

July 27, 2025

Eton Pharmaceuticals Announces FDA Acceptance of New Drug Application for ET-600 (Desmopressin Oral Solution)

July 7, 2025

Eton Pharmaceuticals Announces Addition to Russell 2000® and Russell 3000® Indexes

June 26, 2025

Eton Pharmaceuticals Announces U.S. FDA Approval for KHINDIVI™ (hydrocortisone) Oral Solution

May 27, 2025

Eton Pharmaceuticals to Participate at Upcoming Investor Conferences

May 13, 2025

Eton Pharmaceuticals Reports First Quarter 2025 Financial Results

May 12, 2025

Eton Pharmaceuticals to Report First Quarter 2025 Financial Results on Tuesday, May 13, 2025

April 30, 2025

Eton Pharmaceuticals Announces Submission of NDA for ET-600 (Desmopressin Oral Solution)

April 27, 2025

Eton Pharmaceuticals Out-Licenses International Rights to Increlex®

March 31, 2025

Eton Pharmaceuticals Reports Fourth Quarter 2024 Financial Results

March 17, 2025

Eton Pharmaceuticals Announces Positive Pivotal Clinical Study Results for Product Candidate ET-600

March 13, 2025

Eton Pharmaceuticals to Host Virtual Investor Day and Release Fourth Quarter Earnings Results on March 18, 2025

March 3, 2025

Eton Pharmaceuticals Announces Commercial Launch of Galzin® (zinc acetate) Capsules

March 2, 2025

Eton Pharmaceuticals Expands Patent Portfolio with Issuance of New U.S. Patent for ET-600

February 6, 2025

Eton Pharmaceuticals Announces Extension of PDUFA Goal Date for ET-400

February 5, 2025

Eton Pharmaceuticals Advances Its Commitment to Rare Disease with the Acquisition of Galzin®

January 2, 2025

Calls in 2025

Decks in 2025